Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 1 Adverse events in patients treated with sirolimus-eluting stent (SES group) and in patients treated exclusively with paclitaxel-eluting stent implantation (PES group). (A) Cumulative risk of major adverse events (MACE); (B) death or myocardial infarction (MI); and (C) target vessel revascularization (TVR). CI = confidence interval.
|
